(Reuters) -Hedge fund Starboard Value has taken a stake in Kenvue, the consumer products company that makes Band-Aid, ...
Tylenol, Listerine and Band-Aid maker Kenvue is the latest in the health related sector to attract an activist investor. And ...
Adds Kenvue comment. Kenvue (NYSE:KVUE) needs to focus on fixing its skin, health and beauty segments, Jeff Smith, founder ...
Starboard Value called consumer products company Kenvue a bargain and said its skin health and beauty segment's lackluster ...
Kenvue has a formidable lineup of well-known consumer health brands, such as Aveeno, Tylenol, Band-Aid, Zirtec, Listerine, ...
基金投资者Starboard Value在有报道称该投资者已积累大量股份后,可能会推动 $Kenvue Inc (KVUE)$ 剥离其部分或全部“陷入困境的”皮肤、医疗保健和美容(SHB)部门。 鉴于在过去一年半的时间里,SHB部门一直是该股争论的关键领域,预计Starboard将详细说明它希望管理层对该部门做出的改变——我们怀疑这可能涉及剥离该部门的部分或部。
10月21日|消费者健康产品公司Kenvue (KVUE.US) 美股盘前涨约3.6%,报22.5美元。消息面上,据路透援引两位知情人士称, 对冲 基金Starboard ...
Kenvue shares jumped premarket after The Wall Street Journal reported that Starboard Value has taken a sizable stake in the ...
In the assessment of 12-month price targets, analysts unveil insights for Kenvue, presenting an average target of $24.1, a ...
Starboard Chief Executive Jeff Smith said that Kenvue, the Tylenol-maker spun out from Johnson & Johnson, should drill down on fixing its underperforming skin health and beauty segment, which he ...
Kenvue, Inc. (KVUE – Research Report), the Technology sector company, was revisited by a Wall Street analyst yesterday. Analyst Anna ...
J.P. Morgan analyst Andrea Faria Teixeira has maintained their bullish stance on KVUE stock, giving a Buy rating on October 15. Andrea Faria ...